From: Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris
Alternative cipro prescription n (%) | |||
---|---|---|---|
With bacteriological finding | 28 (58.3) | ||
P. aeruginosa | 6 | ||
Cystic fibrosis pulmonary infection | 3 | ||
Site of infection for with P. aeruginosa without CF# | 3 | ||
Oral cipro | 6 | ||
E. coli | 6 | ||
CNS ¶ | 5 | ||
K. pneumoniae | 3 | ||
MRSA £ | 2 | ||
S. marcescens | 2 | ||
Others * | 4 | ||
Oral cipro | 9 | ||
Intravenous cipro | 13 | ||
Site of infection for non P. aeruginosa$ | 22 | ||
Alternative by another active antibiotic | 28 | ||
Without bacteriological finding | 20 (41.7) | ||
Alternative by another antibiotic | 20 | ||
Site of infection for non bacteriologically documented infection & | 17 | ||
Empiric therapy for fever with current neutropenia | 3 | ||
Intravenous cipro | 13 | ||
Oral cipro | 7 | ||
Total | 48 (100) |